GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Other Income (Expense)

Microba Life Sciences (ASX:MAP) Other Income (Expense) : A$6.88 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Other Income (Expense)?

Microba Life Sciences's other income expense for the Microba Life Sciences's pretax income for the six months ended in Dec. 2023 was A$3.32 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$6.88 Mil.


Microba Life Sciences Other Income (Expense) Historical Data

The historical data trend for Microba Life Sciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Other Income (Expense) Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Other Income (Expense)
4.82 6.74

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) - - 3.18 3.56 3.32

Microba Life Sciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$6.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microba Life Sciences  (ASX:MAP) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines